Obeversen (Ionis-Pharmaceuticals)

N/A

Report date: 2022/05/10 11:41:04
NME

Base Information

Drug NameObeversen (Ionis-Pharmaceuticals)
Drug Alias NameObeversen sodium (Ionis Pharmaceuticals)ION-769357 free acid
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGlial fibrillary acidic protein inhibitorsRNA interference
TargetsGlial fibrillary acidic protein
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A